• Return to Headlines

Shares of Tetraphase Pharm Has Fallen Below Previous 52-Week Low

By Shiri Gupta

Shares of Tetraphase Pharm (NASDAQ:TTPH) traded today at $0.62, breaking its 52-week low. Approximately 156,000 shares have changed hands today, as compared to an average 30-day volume of 555,000 shares.

There is potential upside of 1,033.8% for shares of Tetraphase Pharm based on a current price of $0.62 and an average consensus analyst price target of $7.00. The stock should run into initial resistance at its 50-day moving average (MA) of $0.92 and subsequent resistance at its 200-day MA of $1.57.

Tetraphase Pharmaceuticals, Inc. biopharmaceutical products. The Company offers antibiotics to treat multi-drug resistant bacterial infections. Tetraphase Pharmaceuticals serves customers in the United States.

In the past 52 weeks, Tetraphase Pharm share prices have been bracketed by a current low of $0.62 and a high of $4.35 and are now at $0.62. In the last five trading sessions, the 50-day moving average (MA) has fallen 4.8% while the 200-day MA has slid 3.5%.

SmarTrend recommended that its subscribers protect gains by selling shares of Tetraphase Pharm on April 17th, 2019 by issuing a Downtrend alert when the shares were trading at $1.07. Since that call, shares of Tetraphase Pharm have fallen 41.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows tetraphase pharm

Ticker(s): TTPH